|
Top Stories:
A New Era in San Diego Stem Cell Research
Head of State Stem Cell Institute Comes to Campus in Wake of $43 million Grant to Build Stem Cell Research Facility on Torrey Pines Mesa
Alan Trounson, a well-known stem cell researcher, joked that the first time he came to San Diego, he knew the city had a zoo, but didn’t know it had a university. Much has changed since then. Trounson now heads California’s agency dedicated to stem cell research, while UC San Diego has become one of the major players in that field. more
From Bench to Bedside in One Year: Stem Cell Research
Leads to Potential New Therapy for Rare Blood Disorder
A unique partnership between industry and academia has led to human clinical trials of a new drug for a rare class of blood diseases called myeloproliferative disorders (MPD), which are all driven by the same genetic mutation and can evolve into leukemia. In just one year, collaborative discoveries by stem cell researchers from the University of California, San Diego, Dana-Farber Cancer Institute, the Mayo Clinic and a San Diego pharmaceutical company, TargeGen, moved from identification of the most promising drug candidate to clinical trials for a new drug to fight this degenerative blood disorder, which affects more than 100,000 Americans. more
UC San Diego Researcher Receive
New Faculty Award for Stem Cell Research from
The California Institute for Regenerative Medicine (CIRM)
The latest round of grants for stem cell research has been approved for funding by the 29-member Independent Citizens Oversight Committee (ICOC), governing board of the California Institute for Regenerative Medicine (CIRM). The New Faculty Award to David Traver, assistant professor of biological sciences at the UC-San Diego, will fund his research into how the stem cells of the blood-forming system are generated, providing $2,803,375 over five years. more
Targeting Astrocytes Slows Disease Progression in ALS
In what the researchers say could be promising news in the quest to find a therapy to slow the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, scientists at the University of California, San Diego (UCSD) School of Medicine have shown that targeting neuronal support cells called astrocytes sharply slows disease progression in mice. more
Stem Cell Research Facilities Expanding at UCSD
San Diego, CA, June 5, 2007 -- The University of California, San Diego (UCSD) Human Stem Cell Core Facility, which supports multiple research projects using stem cells to advance the understanding and ultimately the treatment of disease and injury, will receive a $2.8 million Shared Research Laboratory Grant from the California Institute for Regenerative Medicine (CIRM). The funding will be used to upgrade the current core facility, and to support the establishment of a new satellite facility to expand the resources available to investigators. more
More Stories
|
